Erste Asset Management GmbH »

Protagonist Therapeutics shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 14k 99.87
2025-12-31 $1.2M 14k 87.93
2025-09-30 $879k 14k 65.14
2025-06-30 $752k 14k 55.69
2025-03-31 $660k 14k 48.88
2024-12-31 $526k 14k 38.96

More positions owned by Erste Asset Management GmbH

Gilead Sciences Common Stock (GILD)
Amphenol Corp Common Stock (APH)
Starbucks Corp Common Stock (SBUX)
Morgan Stanley Common Stock (MS)
Home Depot Common Stock (HD)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Ishares Gold Tr Fund/ETF (IAU)
Walmart Common Stock (WMT)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Common Stock (META)
Lam Research Corp Common Stock (LRCX)

View all positions for Erste Asset Management GmbH

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
UBS Group
Rtw Investments
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Henderson Group
Johnson & Johnson
Invesco
Geode Capital Management
Citadel Advisors
Woodline Partners
Bank of America Corporation

View all funds holding Protagonist Therapeutics